Former EMS protocol required paramedics to transport mothers and babies in separate ambulances. Now crews can carry them together, giving a mother and her child more time to connect.
Health
Alzheimer’s drug that can slow disease gets backing from FDA advisers
If it wins final approval, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. that’s been shown to convincingly slow cognitive decline and memory problems due to Alzheimer’s.
At Safe Harbor in Machias, a place for women in recovery – and their kids
The Down East certified recovery home is one of just two in Maine that allows women to bring their children.
Businesses air concerns about proposed rules of new paid family leave program
Some companies that plan to offer their own programs object to paying into the state program during its 16-month startup period. The 1% payroll tax is split evenly between employers and their workers.
Skowhegan hospital looks to build medical office building
Redington-Fairview General Hospital has submitted a proposal to the town’s Planning Board for a three-story, 24,000-square-foot building and expanded parking.
Maine woman files class-action lawsuit against Cigna for denying coverage of weight-loss medication
Jamie Whittemore’s suit, which her attorneys believe is the first of its kind in the nation, says drugs to treat obesity must be covered because the Affordable Care Act prohibits discrimination based on a disability.
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
The drug is the first in a series of psychedelics – including LSD and psilocybin – that are expected to come before the agency in the next few years.
Being a patient is getting harder in a strained and complex U.S. health care system
Health care delivery experts say patients in the U.S. need more help dealing with a system that is growing increasingly complex.
Maine stocks PFAS-laden waters with fish, warns ‘do not eat’
Scientists worry that some anglers will still consume the trout tainted by forever chemicals. One environmental watchdog group calls the state Department of Inland Fisheries and Wildlife practice ‘super disturbing.’
Psychedelic drug MDMA faces questions as FDA considers approval for PTSD
FDA scientists said it’s difficult to know how much of the improvement came from MDMA versus simply undergoing intensive therapy.